Schade, R., Trifiro, G., Herings, R., Mazzaglia, G., Pedersen, L., Sturkenboom, M. (2013). Trends in Utilization of Cabergoline for Neurological Indications in Four European Countries. Do Doctors Comply with Risk Minimization Activities Concerning Heart Valve Fibrosis? A Population-Based Analysis. Intervento presentato a: 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Montréal, Canada.

Trends in Utilization of Cabergoline for Neurological Indications in Four European Countries. Do Doctors Comply with Risk Minimization Activities Concerning Heart Valve Fibrosis? A Population-Based Analysis

Mazzaglia G;
2013

abstract
Cabergoline; Electronic Healthcare database; Risk Minimization; Heart Valve Fibrosis
English
29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
2013
2013
22
supplement 1, SI
511
511
reserved
Schade, R., Trifiro, G., Herings, R., Mazzaglia, G., Pedersen, L., Sturkenboom, M. (2013). Trends in Utilization of Cabergoline for Neurological Indications in Four European Countries. Do Doctors Comply with Risk Minimization Activities Concerning Heart Valve Fibrosis? A Population-Based Analysis. Intervento presentato a: 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Montréal, Canada.
File in questo prodotto:
File Dimensione Formato  
2013-Pharmacoepidemiology_and_Drug_Safety.pdf

Solo gestori archivio

Dimensione 3.63 MB
Formato Adobe PDF
3.63 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/225685
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact